House mark and animal feed pre-mix classification principles determine whether products fall under medicament or feed headings.

A broad company logo used across stationery, records and multiple products is treated as a house mark, not a product-specific brand name, so it does not by itself make a medicament a patent or proprietary product under Heading 3003 read with Chapter 30 Note 2. The classification claim was therefore rejected. Amprolium premix intended to be mixed into animal feed for prevention of coccidiosis in poultry is characterised by its composition, presentation and use as a feed preparation, not as a medicament. It was accordingly classifiable under Heading 23.02 as an animal feed pre-mix, and the consequential penalties and impugned classification could not be sustained.

---

---

Issues: (i) Whether medicaments bearing a company logo used broadly across the manufacturer's business, and not confined to a particular product, were classifiable as patent or proprietary medicaments under Heading 3003 read with Note 2 to Chapter 30. (ii) Whether amprolium premix, used in animal feed for prevention of coccidiosis in poultry, was classifiable as a medicament or as a pre-mix / animal feed preparation under Heading 23.02.

Issue (i): Whether medicaments bearing a company logo used broadly across the manufacturer's business, and not confined to a particular product, were classifiable as patent or proprietary medicaments under Heading 3003 read with Note 2 to Chapter 30.

Analysis: The use of a mark as a patent or proprietary medicament depends on whether the mark functions as a brand name or invented name in relation to the particular product. A device or logo used generally across correspondence, stationery, employee cards, factory records, and multiple products may indicate a house mark or company emblem rather than a product-specific brand name. Where the goods are otherwise described only by their generic names, the mere presence of such a broad company logo is insufficient to bring them within the category of patent or proprietary medicaments.

Conclusion: The classification as patent or proprietary medicaments was not sustainable, and the appellants' claim was accepted.

Issue (ii): Whether amprolium premix, used in animal feed for prevention of coccidiosis in poultry, was classifiable as a medicament or as a pre-mix / animal feed preparation under Heading 23.02.

Analysis: A pre-mix containing amprolium with a carrier, intended to be mixed in feed and used for prevention of coccidiosis, answers to the description of an animal feed preparation. The product's presentation, composition, and manner of use supported classification as a pre-mix rather than as a medicament. The medicinal character attributed by the department was displaced by the product's dominant use as an ingredient in animal feed.

Conclusion: The product was classifiable under Heading 23.02 as an animal feed preparation / pre-mix, not as a medicament.

Final Conclusion: The impugned classification and consequential penalties could not be sustained, and the appeals succeeded.

Ratio Decidendi: A broad company house mark used across multiple products and business materials does not, by itself, make a medicament a patent or proprietary product; likewise, a substance presented and used as a feed pre-mix for animal nutrition or prophylaxis is classifiable as an animal feed preparation when that is its commercial and functional identity.

---